Repository logo
 
Loading...
Thumbnail Image
Publication

Engineered non-invasive functionalized dendrimer/dendron-entrapped/complexed gold nanoparticles as a novel class of theranostic (radio)pharmaceuticals in cancer therapy

Use this identifier to reference this record.

Advisor(s)

Abstract(s)

Nanomedicine represents a very significant contribution in current cancer treatment; in addition to surgical intervention, radiation and chemotherapeutic agents that unfortunately also kill healthy cells, inducing highly deleterious and often life-threatening side effects in the patient. Of the numerous nanoparticles used against cancer, gold nanoparticles had been developed for therapeutic applications. Inter alia, a large variety of den drimers, i.e. soft artificial macromolecules, have turned up as non-viral functional nanocarriers for entrapping drugs, imaging agents, and targeting molecules. This review will provide insights into the design, synthesis, functionalization, and development in biomedicine of engineered functionalized hybrid dendrimer-tangled gold nanoparticles in the domain of cancer theranostic. Several aspects are highlighted and discussed such as 1) dendrimer-entrapped gold(0) hybrid nanoparticles for the targeted imaging and treatment of cancer cells, 2) dendrimer encapsulating gold(0) nanoparticles (Au DENPs) for the delivery of genes, 3) Au DENPs for drug delivery applications, 4) dendrimer encapsulating gold radioactive nanoparticles for radiotherapy, and 5) dendrimer/dendron-complexed gold(III) nanoparticles as technologies to take down cancer cells.

Description

Keywords

Dendrimers Dendrons Gold(0)/(III) nanoparticles Gene and drug delivery Cancer therapy Theranostic strategy . Faculdade de Ciências Exatas e da Engenharia Centro de Química da Madeira

Citation

Mignani, S., Shi, X., Ceña, V., Rodrigues, J., Tomas, H., & Majoral, J. P. (2021). Engineered non-invasive functionalized dendrimer/dendron-entrapped/complexed gold nanoparticles as a novel class of theranostic (radio) pharmaceuticals in cancer therapy. Journal of Controlled Release, 332, 346-366. https://doi.org/10.1016/j.jconrel.2021.03.003

Organizational Units

Journal Issue